Organism name | Alpinia blepharocalyx |
---|---|
Genus | Alpinia |
Family | Zingiberaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Alpinia blepharocalyx |
---|---|
Linked NCBI taxonomy ID | 105668 |
Linked level | species |
Family in NCBI taxonomy | Zingiberaceae |
---|---|
ID | 4642 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Liliopsida |
---|---|
ID | 4447 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006919 |
4,4'-Dihydroxychalcone
|
CHEMBL145927
|
C007423
|
No. 92 | No. 13 | |||
C00006954 |
Helichrysetin
/ 4,2',4'-Trihydroxy-6'-methoxychalcone |
CHEMBL507998
|
C061023
|
No. 92 | No. 13 | |||
C00014289 |
Calyxin K
|
CHEMBL455334
CHEMBL450782 |
No. 200 | |||||
C00014576 |
Epicalyxin H
|
CHEMBL1926699
|
No. 200 | |||||
C00008123 |
Calyxin A
|
No. 200 | ||||||
C00008124 |
Calyxin B
|
No. 200 | ||||||
C00014285 |
Calyxin C
/ 2,3-Dihydro-7-hydroxy-8-[(1S,2E,5S)-5-hydroxy-1,7-bis(4-hydroxyphenyl)-2-heptenyl]-2-(4-hydroxyphenyl)-5-methoxy-4H-1-benzopyran-4-one |
No. 200 | ||||||
C00014286 |
Calyxin D
/ 2,3-Dihydro-7-hydroxy-8-[(1R,2E,5S)-5-hydroxy-1,7-bis(4-hydroxyphenyl)-2-heptenyl]-2-(4-hydroxyphenyl)-5-methoxy-4H-1-benzopyran-4-one |
No. 200 | ||||||
C00014287 |
Calyxin G
|
CHEMBL455334
CHEMBL450782 |
No. 200 | |||||
C00014575 |
Calyxin H
|
CHEMBL1926699
|
No. 200 | |||||
C00014571 |
Deoxycalyxin A
|
CHEMBL504530
|
No. 200 | |||||
C00014290 |
Calyxin M
|
CHEMBL457496
|
No. 200 | |||||
C00014291 |
Epicalyxin C
|
No. 200 | ||||||
C00014292 |
Epicalyxin D
|
No. 200 | ||||||
C00014293 |
Epicalyxin G
|
CHEMBL455334
CHEMBL450782 |
No. 200 | |||||
C00014573 |
Calyxin F
|
No. 200 | ||||||
C00014295 |
Epicalyxin K
|
CHEMBL455334
CHEMBL450782 |
No. 200 | |||||
C00014296 |
Epicalyxin M
|
CHEMBL457496
|
No. 200 | |||||
C00014574 |
Calyxin L
/ Epicalyxin F |
CHEMBL451268
CHEMBL447717 |
No. 200 | |||||
C00014572 |
Epicalyxin B
/ 3-epi-Calyxin B |
No. 200 | ||||||
C00019308 |
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 | ||
C00045571 |
p-Hydroxy-5,6-dehydrokawain
/ 4'-Hydroxy-5,6-dehydrokawain |
CHEMBL464111
|
No. 1312 | No. 63 | ||||
C00014578 |
Epicalyxin I
|
CHEMBL455049
CHEMBL503028 |
No. 1371 | |||||
C00014294 |
Epicalyxin J
|
CHEMBL510115
|
No. 1371 | |||||
C00014577 |
Calyxin I
|
CHEMBL455049
CHEMBL503028 |
No. 1371 | |||||
C00014288 |
Calyxin J
|
CHEMBL510115
|
No. 1371 | |||||
C00014581 |
Blepharocalyxin E
|
No. 1371 | ||||||
C00014580 |
Blepharocalyxin B
/ (-)-Blepharocalyxin B |
No. 1371 | ||||||
C00014579 |
Blepharocalyxin A
/ (-)-Blepharocalyxin A |
No. 1371 | ||||||
C00002665 |
Phloroglucinol
|
CHEMBL473159
|
D010696
|
3 / 4 / 2 | 8 / 2 | No. 1590 | No. 82 | |
C00002657 |
p-Formylphenol
/ 4-Hydroxybenzaldehyde / p-Hydroxybenzaldehyde |
CHEMBL14193
|
C011483
|
3 / 2 / 2 | No. 2076 | |||
C00032012 |
Methyl p-coumarate
/ Methyl p-hydroxycinnamate / Methyl 4-hydroxy cinnamate / 4-Hydroxycinnamic acid methyl ester |
CHEMBL146816
|
C057918
|
6 / 2 / 4 | No. 2416 | |||
C00046202 |
Neocalyxin A
|
CHEMBL518161
|
No. 4904 | |||||
C00046203 |
Neocalyxin B
/ (-)-Neocalyxin B |
CHEMBL518161
|
No. 4904 | |||||
C00045687 |
Blepharocalyxin C
/ (+)-Blepharocalyxin C |
CHEMBL448211
|
No. 5225 | |||||
C00045688 |
Blepharocalyxin D
/ (+)-Blepharocalyxin D |
CHEMBL446847
|
No. 5225 |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00019308 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00019308 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00032012 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00019308 | 0 / 0 |
P51649 | Succinate-semialdehyde dehydrogenase, mitochondrial | Oxidoreductase | C00002657 | 1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00032012 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00032012 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00032012 | 1 / 2 |
P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00002657 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00032012 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00019308 | 0 / 0 |
P00734 | Prothrombin | S1A | C00019308 | 4 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00002665 | 4 / 2 |
P80404 | 4-aminobutyrate aminotransferase, mitochondrial | Transferase | C00002657 | 1 / 1 |
P56817 | Beta-secretase 1 | A1A | C00002665 | 0 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00032012 | 0 / 1 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002665 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002665
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00002665
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00002665
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002665
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00002665
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00002665
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00002665
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00002665
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#613163 | Gaba-transaminase deficiency |
P80404
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#601367 | Stroke, ischemic |
P00734
|
#271980 | Succinic semialdehyde dehydrogenase deficiency; ssadhd |
P51649
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
KEGG | name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00835 | Succinic semialdehyde dehydrogenase (SSADH) deficiency |
P51649
(related)
|
H01257 | GABA-transaminase deficiency |
P80404
(related)
|